Skip to main content

Table 1 Patient demographics, disease characteristics and therapy.

From: A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects

Number of patients

N = 65

Surgical margins

 

Mean age (range) in yrs

69(53 - 86)

Negative

62 (95%)

Tumour class(AJCC)

 

Positive

1 (2%)

pTis

3 (5%)

Close

2 (3%)

pT1a

4 (6%)

Hormonal status

 

pT1b

10 (15%)

HR positive

60 (92%)

pT1c

34 (52%)

HR negative

5 (8%)

pT2

14 (22%)

Hormone therapy

 

Max tumour diam. (range) mm

3 - 30

Yes

57 (88%)

Grading

 

No

5 (13%)

G1

12 (18%)

Chemotherapy

9 (14%)

G2

39 (60%)

  

G3

14 (22%)

  

Proliferative index (Ki67) %

   

≤ 15

39 (60%)

  

> 15

26 (40%)

  

Nodal status

   

pN0

58 (89%)

  

pN1(a)

7 (11%)

  
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us